Securian Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,409
| Closed | -$197K | – | 990 |
|
|
2021
Q2 | $197K | Sell |
2,409
-161
| -6% | -$13.2K | ﹤0.01% | 971 |
|
|
2021
Q1 | $244K | Buy |
2,570
+161
| +7% | +$15.3K | 0.01% | 947 |
|
|
2020
Q4 | $149K | Hold |
2,409
| – | – | ﹤0.01% | 971 |
|
|
2020
Q3 | $143K | Sell |
2,409
-161
| -6% | -$9.56K | ﹤0.01% | 983 |
|
|
2020
Q2 | $179K | Sell |
2,570
-160
| -6% | -$11.1K | ﹤0.01% | 947 |
|
|
2020
Q1 | $124K | Sell |
2,730
-160
| -6% | -$7.27K | ﹤0.01% | 963 |
|
|
2019
Q4 | $188K | Sell |
2,890
-529
| -15% | -$34.4K | ﹤0.01% | 987 |
|
|
2019
Q3 | $212K | Sell |
3,419
-396
| -10% | -$24.6K | ﹤0.01% | 966 |
|
|
2019
Q2 | $272K | Sell |
3,815
-160
| -4% | -$11.4K | 0.01% | 939 |
|
|
2019
Q1 | $312K | Sell |
3,975
-161
| -4% | -$12.6K | 0.01% | 916 |
|
|
2018
Q4 | $350K | Buy |
+4,136
| New | +$350K | 0.01% | 856 |
|